Rationale of a Cross-Sectional Descriptive Study on Associated Factors and Prognosis Maternal-Fetal Links to Early Onset Preeclampsia at the University Clinics of Kinshasa, DR Congo
Background:Preeclampsia (PE) is one of the forms of hypertensive diseases that occur
during pregnancy. Early-onset preeclampsia (EOP), which occurred before 34
weeks, proved to be the deadliest. Indeed, it is characterized by a poor
maternal and fetal prognosis. EOP has a disparate incidence in the world
varying between 0.9% and 31%. Several risks factors are associated with the
occurrence of EOP, which is responsible of several adverse obstetrical outcomes. Complications
can affect up to 85% of pregnant women with EOP, especially when EOP appears
very early, before 28 or even 25 weeks’ gestation. Objectives: To determine frequency of EOP at the University
Clinics of Kinshasa, to describe sociodemographic and clinical characteristics
of pregnant women with EOP and to identify its risks factors and its
associationadverse obstetrical outcomes. Methods: The study will be a
cross-sectional analytical study in University Clinics of Kinshasa from January
2016 to December 2022. The minimal size will be 119. Our study populationwill
consist
Brown, M.A., Magee, L.A., Kenny, L.C., Karumanchi, S.A., McCarthy, F.P., Saito, S., et al. (2018) The Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis & Management Recommendations for International Practice. Pregnancy Hypertension, 13, 291-310. https://doi.org/10.1016/j.preghy.2018.05.004
[3]
Carrasco-Wong, I., Aguilera-Olguín, M., Escalona-Rivano, R., Chiarello, D.I., Barragán-Zúñiga, L.J., Sosa-Macías, M., et al. (2021) Syncytiotrophoblast Stress in Early Onset Preeclampsia: The Issues Perpetuating the Syndrome. Placenta, 113, 57-66.
https://doi.org/10.1016/j.placenta.2021.05.002
[4]
Mégevand, N., Berkane, N., Martinez De Tejada, B. and Pechère-Bertschi, A. (2019) Troubles hypertensifs de la grossesse. Revue Médicale Suisse, 15, 1603-1606.
https://doi.org/10.53738/REVMED.2019.15.662.1603
[5]
Tranquilli, A.L., Brown, M.A., Zeeman, G.G., Dekker, G. and Sibai, B.M. (2013) The Definition of Severe and Early-Onset Preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Pregnancy Hypertension: An International Journal of Women’s Cardiovascular Health, 3, 44-47.
https://doi.org/10.1016/j.preghy.2012.11.001
Sengeyi, M.A.D., et al. (2011) Désordres hypertensifs au cours de la grossesse aux Cliniques Universitaires de Kinshasa Hypertensive Disorders Occurring during Pregnancy at the Kinshasa University Hospital. Annales Africaines de Médecine, 4, 756-762.
https://anafrimed.net/desordres-hypertensifs-au-cours-de-la-grossesse-aux-cliniques-universitaires-de-kinshasa-hypertensive-disorders-occurring-during-pregnancy-at-the-kinshasa-university-hospital
[8]
Sentilhes, L., Schmitz, T. and Lansac, J. (2022) Obstétrique: Pour le praticien. 7th Edition, Elsevier-Masson, Issy-les-Moulineaux. (Pour le praticien).
[9]
Sibai, B.M. and Barton, J.R. (2007) Expectant Management of Severe Preeclampsia Remote from Term: Patient Selection, Treatment, and Delivery Indications. AJOG, 196, 514.e1-514.e9. https://doi.org/10.1016/j.ajog.2007.02.021
[10]
Sauvegrain, P., Camilleri, C., Tessier, V. and Deneux, C. (2022) Le point de vue des usagères sur l’information autour de la prééclampsie: Une enquête en ligne. Gynécologie Obstétrique Fertilité & Sénologie, 50, 499-501.
https://doi.org/10.1016/j.gofs.2022.01.004
[11]
Lisonkova, S. and Joseph, K.S. (2013) Incidence of Preeclampsia: Risk Factors and Outcomes Associated with Early- versus Late-Onset Disease. American Journal of Obstetrics and Gynecology, 209, 544.e1-544.e12.
https://doi.org/10.1016/j.ajog.2013.08.019
[12]
Nana, A.N., Koki, G., PEée, E., Esiene, A., Mbu, R. and Bella, A. (2015) Les Lésions Rétiniennes au Cours de la Prééclampsie/éclampsie et leur Valeur Prédictive sur le Devenir de la Grossesse. Health Sciences and Disease, 16, 2.
http://www.hsd-fmsb.org/index.php/hsd/article/view/450
[13]
Benjelloun, A.T., Benchrifi, Y., Mahdaoui, S. and Samouh, N. (2020) Epidémiologie de la prééclampsie dans la région du grand Casablanca. Case Series, 2, Article No. 112.
[14]
Roland, V.V., Tozin, R.R., Marie, M.M.J., Etienne, M., Christophe, M.T., Dieudonne, V.N., et al. (2020) Epidemiological and Clinical Profile of Severe Pre-Eclampsia at University Clinics of Kinshasa.
[15]
Elongi, J.P., Tandu, B., Spitz, B. and Verdonck, F. (2011) Influence of the Seasonal Variation on the Prevalence of Pre-Eclampsia in Kinshasa. Gynecologie, Obstetrique & Fertilite, 39, 132-135. https://doi.org/10.1016/j.gyobfe.2010.12.010
[16]
Weitzner, O., Yagur, Y., Weissbach, T., Man El, G. and Biron-Shental, T. (2020) Preeclampsia: Risk Factors and Neonatal Outcomes Associated with Early- versus Late-Onset Diseases. The Journal of Maternal-Fetal & Neonatal Medicine, 33, 780-784.
https://doi.org/10.1080/14767058.2018.1500551
[17]
Cisse, C.T., Thiam, M. and Moreau, J.C. (2004) Preeclampsia: Current Aspects of Physiopathology, Clinic and Treatment. Dakar Medical, 49, 152-161.
[18]
Tsatsaris, V., Fournier, T. and Winer, N. (2008) Physiopathologie de la prééclampsie. Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 37, 16-23.
https://doi.org/10.1016/j.jgyn.2007.08.003
[19]
Fournier, T. and Vassilis, T. (2008) Développement du placenta humain et physiopathologie de la pré-éclampsie—Human placental development and pathophysiology of preeclampsia. Métabolismes Hormones Diabètes et Nutrition (XII), n° 4, juillet-août 2008 et n° 5, sPEtembre-octobre.
[20]
Vinatier, D., Prolongeau, J.F., Dufour, P., Tordjeman, N., Theeten, G. and Depret, S. (1995) Physiopathology of Pre-Eclampsia: The Role of Immunology. Journal de Gynécologie, Obstétrique et Biologie de la Reproduction (Paris), 24, 387-399.
[21]
Prééclampsie en milieu africain (2005) épidémiologie et pronostic au CHU de Dakar.
[22]
Bangambe, B.J., Mbanzulu, P.N., Kitenge, K.K. and Lokomba, B.V. (2011) Low Dose Aspirin and Calcium in the Prevention of Pre-Eclampsia in Nulliparous Pregnant Women at Kinshasa, the Democratic Republic of Congo. Annales Africaines de Medicine, 5, 936-942.
https://anafrimed.net/place-de-laspirine-a-faible-dose-et-du-calcium-dans-la-prevention-de-la-pre-eclampsie-chez-la-primigeste-de-kinshasa-republique-democratique-du-congo-low-dose-aspirin-and-calcium-in-the-prev/
[23]
Beaufils, M. (2000) Aspirin and Prevention of Pre-Eclampsia. La Revue de Médecine Interne, 21, 68s-74s.
[24]
Rana, S., Lemoine, E., Granger, J. and Karumanchi, S.A. (2019) Compendium on the Pathophysiology and Treatment of Hypertension Preeclampsia. Circulation Research, 124, 1094-1112. https://doi.org/10.1161/CIRCRESAHA.118.313276
[25]
Serreau, R. (2010) Collége national des gynécologues et obstétriciens, Société française de médecine périnatale, Société française de néonatalogie, Société française d’anesthésie et de réanimation. [Drugs during Preeclampsia. Fetal Risks and Pharmacology]. Annales Françaises d’Anesthésie et de Réanimation, 29, e37-e46.
[26]
Rozenberg, P. (2006) Magnesium Sulphate for the Management of Preeclampsia. Gynecologie, Obstetrique & Fertilite, 34, 54-59.
https://doi.org/10.1016/j.gyobfe.2005.06.025
[27]
Bouet, P.E., Gillard, P., Descamps, P. and Sentilhes, L. (2014) Management of Pre-Eclampsia. Revue du Praticien, 64, 1145-1149, 1151-1152.
[28]
Lecarpentier, E., Haddad, B., Goffinet, F. and Tsatsaris, V. (2016) Medical Approaches for Managing Preeclampsia. La Presse Médicale, 45, 638-645.
https://doi.org/10.1016/j.lpm.2016.04.017
[29]
Méhats, C., Miralles, F. and Vaiman, D. (2017) New Perspectives on Preeclampsia. Medical Sciences (Paris), 33, 1079-1088.
https://doi.org/10.1051/medsci/20173312015
[30]
Deruelle, P., Girard, J.M., Coutty, N. and Subtil, D. (2010) Prevention of Preeclampsia. Annales Françaises d’Anesthésie et de Réanimation, 29, e31-e35.
https://doi.org/10.1016/j.annfar.2010.02.014
[31]
Randrianarivony, E.M.S. (2018) Pronostic et facteurs associés à l’apparition précoce des prééclampsies à la Maternité de BEFELATANANA. Thèse de médécine.
[32]
Wójtowicz, A., Zembala-Szczerba, M., Babczyk, D., Kołodziejczyk-Pietruszka, M., Lewaczyńska, O. and Huras, H. (2019) Early- and Late-Onset Preeclampsia: A Comprehensive Cohort Study of Laboratory and Clinical Findings According to the New ISHHP Criteria. International Journal of Hypertension, 2019, Article ID: 4108271. https://doi.org/10.1155/2019/4108271
[33]
Seeho, S.K., Algert, C.S., Roberts, C.L. and Ford, J.B. (2016) Early-Onset Preeclampsia Appears to Discourage Subsequent Pregnancy but the Risks May Be Overestimated. AJOG, 215, 785.e1-785.e8. https://doi.org/10.1016/j.ajog.2016.07.038
[34]
Jantasing, S. and Tanawattanacharoen, S. (2008) Perinatal Outcomes in Severe Preeclamptic Women between 24 - 33+6 Weeks’ Gestation. Journal of the Medical Association of Thailand, 91, 25-30.
[35]
Robillard, P.Y., Boukerrou, M., Dekker, G., Scioscia, M., Bonsante, F., Boumahni, B., et al. (2021) Risk Factors for Early and Late Onset Preeclampsia in Reunion Island: Multivariate Analysis of Singleton and Twin Pregnancies. A 20-Year Population-Based Cohort of 2120 Preeclampsia Cases. Reproductive Medicine, 2, 131-143.
https://doi.org/10.3390/reprodmed2030014
[36]
Teka, H., Yemane, A., Abraha, H.E., Berhe, E., Tadesse, H., Gebru, F., et al. (2023) Clinical Presentation, Maternal-Fetal, and Neonatal Outcomes of Early-Onset versus Late Onset Preeclampsia-Eclampsia Syndrome in a Teaching Hospital in a Low-Resource Setting: A Retrospective Cohort Study. PLOS ONE, 18, e0281952.
https://doi.org/10.1371/journal.pone.0281952
[37]
Wadhwani, P., Saha, P.K., Kalra, J.K., Gainder, S. and Sundaram, V. (2020) A Study to Compare Maternal and Perinatal Outcome in Early vs. Late Onset Preeclampsia. Obstetrics & Gynecology Science, 63, 270-277.
https://doi.org/10.5468/ogs.2020.63.3.270
[38]
Beaufils, M. (2011) Secondary Cardiovascular Risk and Pre-Eclampsia. La Revue de Médecine Interne, 32, S36-S40. https://doi.org/10.1016/j.revmed.2011.02.024
[39]
Cournot, M., Lairez, O. and Medzech, B. (2018) Preeclampsia: A Challenge Also for Cardiologists. Annales de Cardiologie et d’Angéiologie (Paris), 67, 280-287.
https://doi.org/10.1016/j.ancard.2018.03.005
[40]
Olié, V. (2021) Hypertensive Disorders of Pregnancy and Early Cardiovascular Diseases. Gynécologie Obstétrique Fertilité & Sénologie, 49, 879-880.
[41]
Wang, X. and Ji, X. (2020) Sample Size Estimation in Clinical Research. Chest, 158, S12-S20. https://doi.org/10.1016/j.chest.2020.03.010
[42]
You, S.H., Cheng, P.J., Chung, T.T., Kuo, C.F., Wu, H.M. and Chu, P.H. (2018) Population-Based Trends and Risk Factors of Early- and Late-Onset Preeclampsia in Taiwan 2001-2014. BMC Pregnancy and Childbirth, 18, Article No. 199.
https://doi.org/10.1186/s12884-018-1845-7
[43]
Ratsiatosika, A.T., Razafimanantsoa, E., Andriantoky, V.B., Ravoavison, N., Andrianampanalinarivo Hery, R., Boukerrou, M., Iacobelli, S. and Robillard, P.Y. (2018) Incidence and Natural History of Preeclampsia/Eclampsia at the University Maternity of Antananarivo, Madagascar: High Prevalence of the Early-Onset Condition. The Journal of Maternal-Fetal & Neonatal Medicine, 32, 3266-3271.
https://doi.org/10.1080/14767058.2018.1462323
